Occipital Biophoton Therapy for Central Sensitization and Gulf War Illness: A Distributed Quantum-Neurobiological Framework Mitigating Mitochondrial Dual-Pathway Dysfunction and Diurnal Hepatic Gating Bottlenecks

This theoretical paper introduces Occipital Biophoton Therapy, a novel, non-invasive quantum-neurobiological framework designed to repair distributed central nervous system network failures in central sensitization syndromes (such as fibromyalgia and Gulf War Illness) and cortical hyper-excitability. The architecture integrates dual mitochondrial pathways (metabolic energy collapse vs. inflammatory immune cascades), circadian hepatic enzyme kinetics (diurnal UGT1A1 bottlenecks leading to recurrent afternoon indirect bilirubin peaks), and ultra-weak photon emission (UPE) coherence. Utilizing 3D Finite-Difference Time-Domain (FDTD) modeling and stochastic Adler-type equations, we demonstrate how a passive, sub-thermal crystalline waveguide array (fabricated from high-purity sapphire or quartz) can efficiently couple with the high-impedance cranial boundary over the occipital gateway. This configuration enables gentle, systemic entrainment and baseline bioenergetic stabilization without the macro-flux artifacts, thermal noise, or electrical synchronization surges associated with active photobiomodulation protocols. Multi-tier bioenergetic, transcriptomic, and hepatic biomarker tracking configurations for clinical validation and veteran care are discussed.